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Benign bile duct strictures are commonly caused by stones, 
bile duct injury, sclerosing cholangitis, chronic pancreatitis, 
and congenital abnormalities. Bile duct changes caused by 
portal hypertension represent another group of uncommon 
causes of benign stricture. 
The earliest evidence of portal biliopathy was described by 
Hunt in 1965.1 Portal cavernoma biliopathy (PCB) is a rare 
condition caused by cavernomatous transformation of an 
extra-hepatic portal vein thrombosis (EHPVT). It is rarely 
symptomatic; however, due to compression of the biliary tree, 
it can result in biliary obstruction, choledocholithiasis, jaun-
dice, and cholangitis.
Endoscopic therapy for symptomatic PCB is a matter of 
discussion since this condition is rare.2
We present a rare case of symptomatic PCB with a common 
bile duct (CBD) stricture, refractory to conventional endo-
scopic therapy in a patient unfit for surgery. Owing to the risk 
of repeated plastic stent exchange, we chose a more definite 
endoscopic approach with temporary placement of fully-cov-
ered self-expandable metal stent (fcSEMS). In this paper, we 
also report our successful results following application of 
fcSEMS.
An 82-year-old man presented to our hospital with fever, 
right-upper quadrant abdominal pain, and jaundice. He had 
undergone cholecystectomy at another hospital for acute cho-
lecystitis in 2002, complicated with an EHPVT. In addition, he 
had a history of aortic stenosis, hypertension, and congestive 
heart failure.
His laboratory values were indicative of leukocytosis 
(16.700/uL) and elevated liver enzymes, with a total bilirubin 
of 8.9 mg/dL.
Abdominal ultrasound revealed dilated intrahepatic bile 
ducts (IHBD) and CBD, as well as an EHPVT.
The patient was diagnosed with acute cholangitis and treat-
ed with antibiotics. Endoscopic retrograde cholangio-pancrea-
tography (ERCP) showed asymmetric stenosis in the middle 
portion of the CBD (compatible with portal biliopathy type I2) 
and some small stones above it, with dilation of the proximal 
CBD and IHBD (Fig. 1A). After sphincterotomy and careful 
stone extraction with Dormia’s basket, a 10-Fr plastic stent was 
placed. Balloon dilation was avoided due to hemobilia risk, 
which has been reported before.3,4
Abdominal computed tomography (CT) scan with contrast 
revealed a portal cavernoma compressing the middle seg-
ment of the CBD and causing the stricture seen during ERCP 
(Fig. 2).
The patient was not a candidate for portal decompression 
(transjugular portosystemic shunt was not feasible and he was 
unfit for surgery due to his advanced age and comorbidities), 
so progressive biliary plastic stenting was performed every 3 
months. However, after one year, there was no improvement 
in the CBD stenosis and the patient still had elevated liver en-
zymes and IHBD dilation.
Following failure of progressive plastic stenting, temporary 
placement of a 80×10-mm fcSEMS (Wallflex®; Boston Sci-
entific, Marlborough, MA, USA) was planned. The stent was 
deployed (Fig. 1B) and removed 6 months later (thereafter) 
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without complications and revealing improvement of the 
stricture (Fig. 1C).
Liver enzymes became normal, the patient remained as-
ymptomatic, and there was no need for additional endoscopic 
therapy in the last 12 months.
Currently, data on the endoscopic treatment of portal bili-
opathy strictures are insufficient.5 As for endoscopic therapy, 
the risk of hemobilia has been studied as a major concern 
during endoscopic management of PCB. In particular, in-
tra-choledochal varices, masquerading as filling defects, may 
be the source of bleeding during calculi extraction. Moreover, 
manipulation of the bile duct also carries a significant risk of 
complications. Hemobilia has also been reported for other 
interventions6 such as exchange of plastic stents, pneumatic 
balloon dilatation of stricture, and balloon-occluding cholan-
giogram during endoscopic management of PCB.
Therefore, surgery is advised for symptomatic cases of PCB, 
whenever possible.
When surgery is not feasible or the patient is not fit for 
surgery (which was the case of our patient due to advanced 
age and comorbidities), plastic stenting is advised. However, 
it is also important to remember that repeated plastic stenting 
carries a possible risk of complications and, in refractory stric-
tures, infinite exchanging of stents should ideally be avoided.
There are no guidelines regarding the use of SEMS in 
symptomatic PCB mainly due to very limited experience.5 
Moreover, cases managed with a successful and uncomplicat-
ed temporary placement of fcSEMS have been rarely report-
ed.7,8 Apart from possible migration, as with other strictures, 
excessive bleeding has been reported during removal of the 
metallic stent.9 However, in this report, a fcSEMS was the first 
treatment approach, which is not routinely recommended.
Fig. 1. (A) Cholangiograms obtained during endoscopic retrograde cholangio-pancreatography (ERCP). Asymmetric stenosis in the middle portion of the common 
bile duct (CBD) (“pseudocholangiocarcinoma sign”) with small stones above it and dilation of the proximal biliary ducts. (B) Following failure of progressive plastic 
stenting, a 80×10-mm fully-covered self-expandable metal stents (fcSEMS) was placed. (C) Stent removal 6 months thereafter revealed improvement in the stenotic 
segment of the CBD.
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Fig. 2. Abdominal computed tomography (CT) scan with contrast showing typical changes of portal biliopathy including dilated peri-portal venous collaterals with a 
portal cavernoma, 3×2 cm (arrow), compressing the middle segment of the common bile duct (CBD) (with plastic stent in place). (A) Axial and (B) Coronal views.
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According to the results obtained in our case, we believe 
temporary placement of fcSEMS might be a good option 
when surgery is contraindicated, progressive plastic stenting 
fails, and no episodes of hemobilia have occurred during pre-
vious endotherapy. It is reasonable to think that if bleeding 
has not occurred during plastic stent exchanges, the risk for it 
to occur during removal of a metal stent is smaller. However, 
more data are needed regarding this PCB treatment approach. 
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